# XellSmart Biomedical

**Canonical:** https://apis.io/providers/xellsmart/  
**Website:** https://www.xellsmart.com  
**APIs profiled:** 0

XellSmart Biomedical (士泽生物医药) is a clinical-stage biotechnology company based in Suzhou and Shanghai, China, founded in 2021 by Dr. Xiang Li. The company develops clinical-grade, allogeneic, off-the-shelf iPSC-derived cell therapies for central nervous system diseases, with NMPA- and U.S. FDA-cleared registrational clinical trials in Parkinson's disease, spinal cord injury, and ALS. XellSmart is a Qiming Venture Partners portfolio company and publishes no public developer or API surface.

## Kin Score — 5.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 5.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 1.2 |
| Commercial Clarity | 5.3 |
| Access Clarity | 5.3 |

Regulatory layer — **Health**: 10.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Xellsmart Domain Security** — no transport/DNS hardening detected

## Tags

Company, Biotechnology, Cell Therapy, Regenerative Medicine, Neuroscience, Healthcare, China

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/xellsmart/). Scores are computed from the provider's own public artifacts under a published rubric.